triazolam has been researched along with Disease in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conclude that the evaluation of insomnia by nonpsychiatrists is often incomplete and that hypnotic drugs may be inappropriately prescribed by these physicians." | 1.28 | Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians. ( Bauwens, SF; Shorr, RI, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shorr, RI | 1 |
| Bauwens, SF | 1 |
1 other study available for triazolam and Disease
| Article | Year |
|---|---|
Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians.
Topics: Disease; Drug Prescriptions; Drug Utilization; Female; Flurazepam; General Surgery; Humans; Internal | 1992 |